Skip to main content
Shahky Early Access Program Now Available—Sign-up to Learn More
Shahky Early Access Program Now Available—Sign-up to Learn More

Shahky Early Access Program

Thank you for your interest in the Shahky Early Access Program.

*Due to the overwhelming initial response, the program is currently at capacity. We will still accept contact information (from the form below) and keep interested companies information on file. We will notify you as openings become available. 

Please fill out the sign-up form below to learn more about the Shahky, the world’s first system for exosome specific protein analysis.

Exosome Diagnostics is encouraging thought leaders from top pharmaceutical companies and research institutions with programs to pinpoint disease specific biomarkers for diagnostic and/or therapeutic purposes, to contact the company for consideration for the Shahky™ Early Access Program. We will be working with a limited number of high caliber organizations. We will prioritize requests based on the size of the project(s), long term goals, utility in drug development/clinical utility, etc.

  • With Shahky, researchers get the benefit of:
  • Ten microliters of biofluid input
  • Label free detection
  • Four-minute run time
  • High sensitivity and specificity (1000x more sensitive than Western Blots and 100X more sensitive than ELISA)
  • Small desktop footprint - optimal for clinical laboratories
  • Quantitative disease specific protein analysis

To Learn more about the Shahky Early Access Program, please fill out the form below.

* indicates required fields